GPX4 and neoplasm: In NPC models, both compounds have been used to demonstrate that blockade of the cystine–GSH–GPX4 axis sensitizes tumor cells to ferroptotic death, particularly in GPX4-low or xCT-addicted phenotypes [26,79].